S100A9 and neoplasm: Interestingly, while cancer biomarkers are often sought exclusively among cancer cell proteins, S100A9 was traced back to components of the tumour microenvironment (TME), specifically in macrophages and neutrophils at the tumour-liver interface in replacement lesions.